Erratum: Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture (Psychopharmacology DOI: 10.1007/s00213-009-1519-2);Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture

Psychopharmacology

Volumn 205, Issue 1, 2009, Pages 93-106

  Descamps, Amandine ^a   Rousset, Colette ^a   Millan, Mark ^b   Spedding, Michael ^b   Delagrange, Philippe ^b   Cespuglio, Raymond ^a  

^a UNIVERSITÉ LYON 1   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Agomelatine; Antidepressant; Melatonin; Polysomnography; Ramelteon; Rat; S32006; Sleep; Wake

Indexed keywords

AGOMELATINE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; RAMELTEON; S 32006; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; LIGHT DARK CYCLE; MULTICHANNEL RECORDER; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP WAKING CYCLE; SLOW WAVE SLEEP;

EID: 67649418003     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1556-x     Document Type: Erratum

References (75)

1. SM Armstrong OM McNulty B Guardiola-Lemaître JR Redman 1993 Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS) Pharmacol Biochem Behav 46 45 49
2. G Aston-Jones S Chen Y Zhu ML Oshinsky 2001 A neural circuit for circadian regulation of arousal Nat Neurosci 4 732 738 (Pubitemid 32595412)
3. 2 receptors Naunyn-Schmiedeberg's Arch Pharmacol 367 553 561 (Pubitemid 36829452)
4. MP Austin P Mitchell GM Goodwin 2001 Cognitive deficits in depression: possible implications for functional neuropathology Br J Psychiatry 178 200 206 (Pubitemid 32183601)
5. JJ Baskett JB Broad PC Wood JR Duncan MJ Pledger J English J Arendt 2003 Does melatonin improve sleep in older people? A randomized crossover trial Age Ageing 32 164 170 (Pubitemid 36372422)
6. V Bertaina-Anglade CD La Rochelle PA Boyer E Mocaer 2006 Antidepressant-like effect of agomelatine in the learned helplessness model Behav Pharmacol 17 703 713 (Pubitemid 44777263)
7. N Borja KL Daniel 2006 Ramelteon for the treatment of insomnia Clin Therapeutics 28 1540 1555 (Pubitemid 44841983)
8. M Bourin E Mocaër R Porsolt 2004 Antidepressant-like activity of S 20098 in the forced swimming test in rodents. Involvement of melatonin and 5-HT receptors J Psy Neurosci 29 126 133 (Pubitemid 38570217)
9. C Cajochen K Krauchi P Graw A Wirz-Justice 1997 Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis Am J Physiol 272 1189 1196
10. C Cajochen K Kräuchi A Wirz-Justice 2003 Role of melatonin in the regulation of human circadian rhythms and sleep J Neuroendocrinol 15 432 437 (Pubitemid 36395244)
11. R Cespuglio S Marinesco V Baubet B El Kafi 1995 Evidence for a sleep-promoting influence of stress Adv Neuroimmunol 5 145 154
12. R Cespuglio C Rousset G Debilly C Rochat MJ Millan 2005 Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat Psychopharmacology (Berl) 181 639 652 (Pubitemid 41400750)
13. A Chagraoui P Protais T Filloux E Mocaër 2003 Agomelatine (S20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats Psychopharmacology (Berl) 170 17 22 (Pubitemid 37372474)
14. P Clement A Gharib R Cespuglio N Sarda 2003 Changes in sleep-wake cycle architecture and cortical NO release during aging in the rat Neuroscience 116 863 870 (Pubitemid 36160579)
15. S Corbach B Schmelting E Fuchs E Mocaër 2007 Comparison of agomelatine and melatonin for effects in chronically stressed tree shrews, an animal model of depression Eur Neurophyschopharmacol 17 S364
16. EJ Dalton D Rotondi RD Levitan SH Kennedy GM Brown 2000 Use of slow-release melatonin in treatment-resistant depression J Psychiatry Neurosci 25 48 52 (Pubitemid 30143328)
17. P De Deurwaerdère S Navaille KA Berg WP Clarke U Spampinato 2004 Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens J Neurosci 24 3235 3241 (Pubitemid 38451889)
18. 2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models Psychopharmacology (Berl) 199 4 549 568
19. C Dugovic JE Leysen A Wauquier 1989 Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep-wakefulness regulation in the rat Neurosci Lett 104 320 325 (Pubitemid 19231153)
20. C Dugovic A Wauquier JE Leysen R Marrannes PA Jannsen 1989 Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat Psychopharmacology (Berl) 97 436 442 (Pubitemid 19102542)
21. M Erman D Seiden G Zammit S Sainati J Zhang 2006 An efficacy, safety and dose-response study of ramelteon in patients with chronic primary insomnia Sleep 7 17 24 (Pubitemid 43033540)
22. CH Fu SC Williams MJ Brammer J Suckling J Kim AJ Cleare ND Walsh MT Mitterschiffthaler CM Andrew EM Pich ET Bullmore 2007 Neural responses to happy facial expressions in major depression following antidepressant treatment Am J Psychiatry 164 599 607 (Pubitemid 46650191)
23. FP Gibbs J Uriend 1981 The half life of melatonin elimination from rat plasma Endocrinology 109 1796 1798 (Pubitemid 12197483)
24. Z Gorka E Moryl M Papp 1996 Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats Pharmacol Biochem Behav 54 229 234 (Pubitemid 26143104)
25. G Grassi-Zucconi M Semprevivo E Mocaer K Kristensson M Bentivoglio 1996 Melatonin and its new antagonist S-20098 restore synchronized sleep fragmented by experimental trypanosome infection in the rat Brain Res Bull 39 63 68 (Pubitemid 26020607)
26. LM Hack SW Lockley J Arendt DJ Skene 2003 The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects J Biol Rhythms 18 420 429 (Pubitemid 37204464)
27. MC Holmes KL French JR Seckl 1997 Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid gene expression in the hippocampus with food restriction and glucocorticoids J Neurosci 17 4056 4065 (Pubitemid 27220596)
28. R Huber T Deboer B Schwierin I Tobler 1998 Effect of melatonin on sleep and brain temperature in the Djungarian hamster and the rat Physiol Behav 65 77 82 (Pubitemid 28511418)
29. RJ Hughes RL Sack AJ Lewy 1998 The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement Sleep 21 52 68 (Pubitemid 28076736)
30. A Ishikawa Y Kanayama H Matsumura H Tsuchimochi Y Ishida S Nakamura 2006 Selective rapid eye movement sleep deprivation impairs the maintenance of long-term potentiation in the rat hippocampus Eur J Neurosci 24 243 248 (Pubitemid 44050683)
31. S Kantor R Jakus R Bodizs P Halasz G Bagdy 2002 Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift Brain Res 943 105 111 (Pubitemid 34671178)
32. A Karim D Tolbert C Cao 2006 Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia J Clin Pharmacol 46 2 140 148 (Pubitemid 43146444)
33. K Kato K Hirai K Nishiyama O Uchikawa K Fukatsu S Ohkawa Y Kawamata S Hinuma M Miyamoto 2005 Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist Neuropharmacology 48 301 310
34. SH Kennedy R Emsley 2006 Placebo-controlled trial of agomelatine in the treatment of major depressive disorder Eur Neuropsychopharmacol 16 93 100 (Pubitemid 43145814)
35. P Lemoine C Guilleminault E Alvarez 2007 Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine J Clin Psychiatry 68 1723 1732 (Pubitemid 350247502)
36. R Leproult A Van Onderbergen M L'Hermite-Baleriaux E Van Cauter G Copinschi 2005 Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men Clin Endocrinol (Oxf) 63 298 304 (Pubitemid 41233447)
37. AJ Lewy S Ahmed JM Jackson RL Sack 1992 Melatonin shifts human circadian rhythms according to a phase-response curve Chronobiol Int 9 380 392
38. SW Lockley DJ Skene K James K Thapan J Wright J Arendt 2000 Melatonin administration can entrain the free-running circadian system in blind subjects J Endocrinol 164 R1 R6
39. PJ Lucassen VM Heine MB Muller EM van der Beek VM Wiegant ER De Kloet M Joels E Fuchs DF Swaab B Czeh 2006 Stress, depression and hippocampal apoptosis CNS Neurol Disord Drug Targets 5 531 546 (Pubitemid 44523871)
40. R Mahlberg D Kunz 2007 Melatonin excretion levels and polysomnographic sleep parameters in healthy subjects and patients with sleep-related disturbances Sleep Med 8 512 516 (Pubitemid 46978067)
41. S Marinesco C Bonnet R Cespuglio 1999 Influence of stress duration on the sleep rebound induced by immobilization in the rat: a possible role for corticosterone Neuroscience 92 921 933 (Pubitemid 29287538)
42. L Martinet B Guardiola-Lemaître E Mocaër 1996 Rhythms by S 20098, a melatonin agonist, is dose and plasma concentration dependent Pharmacol Biochem Behav 54 713 718
43. MJ Millan 2005 Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies Therapie 60 441 460
44. MJ Millan 2006 Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application Pharmacol Ther 110 135 370
45. MJ Millan F Lejeune A Gobert 2000 Reciprocal autoreceptor and heteroreceptor control of serotoninergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents J Psychopharmacol 14 114 138 (Pubitemid 30389486)
46. MJ Millan A Gobert F Lejeune A Dekeyne A Newman-Tancredi V Pasteau JM Rivet D Cussac 2003 The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways J Pharmacol Exp Ther 306 954 64
47. MJ Millan M Brocco A Gobert A Dekeyne 2005 Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2c receptors blockade Psychopharmacology (Berl) 177 448 458
48. M Miyamoto H Nishikawa Y Doken K Hirai O Uchikawa S Ohkawa 2004 The sleep-promoting action of ramelteon (TAK-375) in freely moving cats Sleep 27 7 1319 1325 (Pubitemid 44138898)
49. JM Monti H Jantos 2006 Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat Eur J Pharmacol 553 163 170 (Pubitemid 44794499)
50. K Mundey S Benloucif K Harsanyi ML Dubocovich PC Zee 2005 Phase-dependent treatment of delayed sleep phase syndrome with melatonin Sleep 28 10 1214 1216
51. JP Olié S Kasper 2007 Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder Int J Neuropsychopharmacol 10 661 673
52. SR Pandi-Perumal V Srinivasan B Poeggeler R Hardeland DP Cardinali 2007 Drug insight: the use of melatoninergic agonists for the treatment of insomnia-focus on ramelteon Nat Clin Pract Neurol 3 221 228 (Pubitemid 46605272)
53. M Papp P Gruca P-A Boyer E Mocaer 2003 Effect of agomelatine in the chronic mild stress model of depression in the rat Neuropsychopharmacology 28 694 703
54. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, San Diego
55. MA Quera Salva B Vanier J Laredo S Hartley F Chapotot C Moulin F Lofaso C Guilleminault 2007 Major depressive disorder, sleep EEG and agomelatine: an open-label study Int J Neuropsychopharmacol 10 691 696 (Pubitemid 47517524)
56. SM Rajaratnam DJ Dijk B Middleton BM Stone J Arendt 2003 Melatonin phase-shifts human circadian rhythms with no evidence of changes in the duration or endogenous melatonin secretion or the 24-hour production of reproductive hormones J Clin Endocrinol Metab 88 4303 4309 (Pubitemid 37153735)
57. JR Redman AJP Francis 1998 Entrainment of rat circadian rhythms by the melatonin agonist S 20098 requires intact suprachiasmatic nuclei but not the pineal J Biological Rhythms 13 39 51 (Pubitemid 128478945)
58. JR Redman B Guardiola-Lemaître M Brown P Delagrange SM Armstrong 1995 Dose-dependent effects of S 20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms Psychopharmacology (Berl) 118 385 390
59. B Rijnbeek SJ de Visser KL Franson AF Cohen JM van Gerven 2003 REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers J Psychopharmacol 17 196 203 (Pubitemid 36753536)
60. T Roth C Stubbs JK Walsh 2005 Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment Sleep 28 303 307 (Pubitemid 40315565)
61. M Schittecatte F Dumont R Machowski C Cornil F Lavergne J Wilmotte 2002 Effects of mirtazapine on sleep polygraphic variables in major depression Neuropsychobiology 46 197 201 (Pubitemid 36173369)
62. AI Sharpley PJ Cowen 1995 Effect of pharmacologic treatments on the sleep of depressed patients Biol Psychiatry 37 85 98
63. AL Sharpley JM Elliott MJ Attenburrw PJ Cowen 1994 Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors Neuropharmacology 33 467 471 (Pubitemid 24168718)
64. HA Slotten S Krekling B Sicard P Pévet 2002 Daily infusion of melatonin entrains circadian activity rhythms in the diurnal rodent Arvicanthis ansorgei Behav Brain Res 133 11 19 (Pubitemid 34603667)
65. 2c receptor antagonist on the rat sleep profile: a comparison to paroxetine Pharmacol Biochem Behav 71 599 605 (Pubitemid 34219210)
66. I Tobler K Jaggi AA Borbely 1994 Effects of melatonin and the melatonin receptor agonist S-20098 on the vigilance states, EEG spectra and cortical temperature in the rat J Pineal Res 16 26 32
67. MH Trivedi AJ Rush R Armitage CM Gullion BD Grannemann PJ Orsulak HP Roffwarg 1999 Effects of fluoxetine on polysomnogram in outpatients with major depression Neuropsychopharmacology 20 447 59
68. R Ursin 2002 Serotonin and sleep Sleep Med Rev 6 57 69 (Pubitemid 35243649)
69. O Van Reeth E Olivares Y Zhang PC Zee E Mocaer R Defrance FW Turek 1997 Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters Brain Res 762 1-2 185 194 (Pubitemid 27315948)
70. GW Vogel A Buffenstein K Minter A Hennessey 1990 Drug effects on REM sleep and on endogenous depression Neurosci Biobehav Rev 14 49 63 (Pubitemid 20115612)
71. AG Wade I Ford G Crawford AD McMahon T Nir M Laudon N Zisapel 2007 Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes Curr Med Res Opin 23 2597 2605 (Pubitemid 350033462)
72. A Winokur KA Gary S Rodner C Rae-Red AT Fernando MP Szuba 2001 Depression, sleep physiology, and antidepressant drugs Depress Anxiety 14 19 28 (Pubitemid 32801613)
73. A Wirz-Justice RH Van den Hoofdakker 1999 Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 15 445 453 (Pubitemid 29369070)
74. FP Zemlan JJ Mulchahey MB Scharf DW Mayleben R Rosenberg A Lankford 2005 The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial J Clin Psychiatry 66 384 390 (Pubitemid 40476763)
75. M Zupancic C Guilleminault 2006 Agomelatine: a preliminary review of a new antidepressant CNS Drugs 20 981 992 (Pubitemid 44912707)